oxstem ocular limited
oxstem ocular limited Company Information
Company Number
10194462
Next Accounts
Apr 2025
Shareholders
oxstem limited
robert maclaren
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
2nd floor, arcadia house, 15 forlease road, maidenhead, berkshire, SL6 1RX
Website
-oxstem ocular limited Estimated Valuation
Pomanda estimates the enterprise value of OXSTEM OCULAR LIMITED at £439k based on a Turnover of £430.1k and 1.02x industry multiple (adjusted for size and gross margin).
oxstem ocular limited Estimated Valuation
Pomanda estimates the enterprise value of OXSTEM OCULAR LIMITED at £0 based on an EBITDA of £-810.2k and a 4.02x industry multiple (adjusted for size and gross margin).
oxstem ocular limited Estimated Valuation
Pomanda estimates the enterprise value of OXSTEM OCULAR LIMITED at £0 based on Net Assets of £-2.3m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Oxstem Ocular Limited Overview
Oxstem Ocular Limited is a dissolved company that was located in maidenhead, SL6 1RX with a Companies House number of 10194462. It operated in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in May 2016, it's largest shareholder was oxstem limited with a 91.7% stake. The last turnover for Oxstem Ocular Limited was estimated at £430.1k.
Upgrade for unlimited company reports & a free credit check
Oxstem Ocular Limited Health Check
Pomanda's financial health check has awarded Oxstem Ocular Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 9 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
9 Weak
Size
annual sales of £430.1k, make it smaller than the average company (£2.8m)
- Oxstem Ocular Limited
£2.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a slower rate (12.1%)
- Oxstem Ocular Limited
12.1% - Industry AVG
Production
with a gross margin of 29.5%, this company has a higher cost of product (49.9%)
- Oxstem Ocular Limited
49.9% - Industry AVG
Profitability
an operating margin of -188.4% make it less profitable than the average company (-12%)
- Oxstem Ocular Limited
-12% - Industry AVG
Employees
with 2 employees, this is below the industry average (39)
- Oxstem Ocular Limited
39 - Industry AVG
Pay Structure
on an average salary of £68.5k, the company has an equivalent pay structure (£68.5k)
- Oxstem Ocular Limited
£68.5k - Industry AVG
Efficiency
resulting in sales per employee of £215k, this is more efficient (£113.9k)
- Oxstem Ocular Limited
£113.9k - Industry AVG
Debtor Days
it gets paid by customers after 131 days, this is later than average (51 days)
- Oxstem Ocular Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 24 days, this is quicker than average (46 days)
- Oxstem Ocular Limited
46 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Oxstem Ocular Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (34 weeks)
0 weeks - Oxstem Ocular Limited
34 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1571.1%, this is a higher level of debt than the average (44.4%)
1571.1% - Oxstem Ocular Limited
44.4% - Industry AVG
OXSTEM OCULAR LIMITED financials
Oxstem Ocular Limited's latest turnover from December 2019 is estimated at £430.1 thousand and the company has net assets of -£2.3 million. According to their latest financial statements, we estimate that Oxstem Ocular Limited has 2 employees and maintains cash reserves of £544 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|
| Tangible Assets | ||||
| Intangible Assets | ||||
| Investments & Other | ||||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | ||||
| Stock & work in progress | ||||
| Trade Debtors | 154,618 | 676,726 | 500,166 | 112,600 |
| Group Debtors | ||||
| Misc Debtors | ||||
| Cash | 544 | 56,376 | 170,368 | |
| misc current assets | 400,000 | |||
| total current assets | 155,162 | 733,102 | 670,534 | 512,600 |
| total assets | 155,162 | 733,102 | 670,534 | 512,600 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | 20,484 | 417,831 | 272,039 | 150,386 |
| Group/Directors Accounts | 2,417,349 | 1,788,001 | 1,152,028 | 512,749 |
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | ||||
| total current liabilities | 2,437,833 | 2,205,832 | 1,424,067 | 663,135 |
| loans | ||||
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | ||||
| provisions | ||||
| total long term liabilities | ||||
| total liabilities | 2,437,833 | 2,205,832 | 1,424,067 | 663,135 |
| net assets | -2,282,671 | -1,472,730 | -753,533 | -150,535 |
| total shareholders funds | -2,282,671 | -1,472,730 | -753,533 | -150,535 |
| Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | ||||
| Amortisation | ||||
| Tax | ||||
| Stock | ||||
| Debtors | -522,108 | 176,560 | 387,566 | 112,600 |
| Creditors | -397,347 | 145,792 | 121,653 | 150,386 |
| Accruals and Deferred Income | ||||
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | ||||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | 629,348 | 635,973 | 639,279 | 512,749 |
| Other Short Term Loans | ||||
| Long term loans | ||||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | ||||
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | -55,832 | -113,992 | 170,368 | |
| overdraft | ||||
| change in cash | -55,832 | -113,992 | 170,368 |
oxstem ocular limited Credit Report and Business Information
Oxstem Ocular Limited Competitor Analysis
Perform a competitor analysis for oxstem ocular limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in SL6 area or any other competitors across 12 key performance metrics.
oxstem ocular limited Ownership
OXSTEM OCULAR LIMITED group structure
Oxstem Ocular Limited has no subsidiary companies.
oxstem ocular limited directors
Oxstem Ocular Limited currently has 2 directors. The longest serving directors include Prof Stephen Davies (May 2016) and Dr Stuart Collinson (Mar 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Prof Stephen Davies | 75 years | May 2016 | - | Director | |
| Dr Stuart Collinson | 65 years | Mar 2019 | - | Director |
P&L
December 2019turnover
430.1k
-79%
operating profit
-810.2k
0%
gross margin
29.6%
+2.36%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2019net assets
-2.3m
+0.55%
total assets
155.2k
-0.79%
cash
544
-0.99%
net assets
Total assets minus all liabilities
oxstem ocular limited company details
company number
10194462
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
May 2016
age
9
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
December 2019
previous names
N/A
accountant
-
auditor
-
address
2nd floor, arcadia house, 15 forlease road, maidenhead, berkshire, SL6 1RX
Bank
-
Legal Advisor
-
oxstem ocular limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to oxstem ocular limited.
oxstem ocular limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for OXSTEM OCULAR LIMITED. This can take several minutes, an email will notify you when this has completed.
oxstem ocular limited Companies House Filings - See Documents
| date | description | view/download |
|---|
